Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
251 Factors evaluated as predictors of exceptional response to PD-1 inhibitors in patients with head and neck squamous cell cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.